Latest Biotechnology News

Luddite Greens repeatedly and viscerally anti-science - Take the Flour Back is the latest incarnationAdam Rutherford in the comments at Comment is free does a better job than Sunny Hundal, so let's accept Sense About Science's Tweeted suggestion and promote him to top billing:Dear Sunny,Some interesting points, and a considered pov, as usual. A couple of things worth noting. I'm interested in the longview of opposition to biotechnology that is based on recombinant DNA. Since its discovery/inventi...

BIO Applauds EPA’s Rejection of a Petition to Retroactively Waive the 2011 Renewable Fuel StandardThe Biotechnology Industry Organization (BIO) today expressed support for the Environmental Protection Agency’s denial of a January 2012 petition by petroleum industry representatives to retroactively waive the 2011 cellulosic biofuel Renewable Volume Obligation under the Renewable Fuel Standard (RFS). Brent Erickson, executive vice president of BIO’s...

Advanced Biological Laboratories' DeepChek® and ViroScore® Suite Clinical Genotyping Solutions For Personalized Treatment of HIV Receive CE Mark for In Vitro Diagnostic UseAdvanced Biological Laboratories (ABL) announced today that DeepChek® and ViroScore® Suite clinical genotyping solutions are now CE-IVD (In Vitro Diagnostics) approved for commercial use in Europe and other countries that recognise CE certification. This approval is further validating the use of our next generation sequencing (NGS) downstream an...

CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department GraduationMATTHEWS, N.C., May 25, 2012 /PRNewswire/ -- CEM Corporation president and CEO Michael J. Collins delivered the commencement address for the University of Texas at Austin Chemistry and Biochemistry Department, which was held on May 18, 2012. Collins received his PhD in Physical Chemistry from the University and has been a member of the Advisory Board for the Chemistry Department at the school...

Sangart Completes Its Series G; Looks For PartnerMid-stage biotech Sangart completes another round of financing and makes big plans for the future of its lead compound for treating tissues deprived of oxygen.

Innovative public-private collaboration to tackle antibiotic researchAstraZeneca and GlaxoSmithKline has welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat from antibiotic r...

ImmunoCellular Therapeutics Receives Approval for NYSE MKT ListingImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced today that its common stock has been approved for listing on the NYSE: MKT. Trading is expected to commence on the NYSE: MKT on Wednesday, May 30th, 2012 under the...

Major Scientific Conference Convened to Review The Safety Of GMO CropsA major international conference scientific meeting titled “Risk Assessment in Agricultural Biotechnology” was held at the University of California, Davis. It was sponsored by the College of Agriculture, The National Association of Stat...

Steirischer Kren macht aktive Enzyme sichtbarBiokatalysatoren kommen immer öfter beim Herstellen von Pharmazeutika zum Einsatz. Das Austrian Centre of Industrial Biotechnology forscht an der Herstellung von Transaminasen im großen Stil und kann deren Aktivität mit einem neuen Testverfahren s...

Fera Pharmaceuticals Preparing Resupply of Methazolamide TabletsFera Pharmaceuticals is pleased to announce availability of Methazolamide Tablets and plans to commence shipping June 1, 2012. “Methazolamide has been in short supply in the US and Fera has been working diligently to ensure patients continue to have access to this important medication” says Phil Hammer, VP of Quality and Manufacturing at Fera....

Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-ChangerBOSTON (TheStreet) -- This week's Biotech Stock Mailbag focuses on two big topics, the upcoming ASCO cancer meeting and Celldex Therapeutics (with some Galena Biopharma thrown in for kicks). I also take a rare detour from biotech stocks to write abou...

Public-private alliance to discover new antibiotics A Europe-wide public-private partnership is to put €224m (£180m) into finding new antibiotics for all manner of bacterial infections such as MRSA. The Innovative Medicines Initiative (IMI) is behind the scheme, which involves GlaxoSmithKlin...

Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & SullivanLONDON, May 25, 2012 /PRNewswire/ -- Increasingly, big pharma is viewing the outsourcing of pharmaceutical manufacturing as a strategic move that would enable them to focus on their core competencies such as R&D. At the same time, the patent expiry of key blockbuster drugs worth $45 billion and biologics worth $30 billion is expected to reduce the capacity utilisation rates of their manuf...

C3 Jian soon to initiate Phase I trial of C16G2C3 Jian, a clinical-stage biotechnology company, has gained FDA approval for investigational new drug application (IND) of C16G2 and expects to begin Phase I trial in July 2012.

Proposal for more stringent review of biotech fish rejected by SenateThe Senate rejected a proposal by Sen. -More-

Novartis calls students to participate in BioCamp at Hyderabad from July 30Novartis India is conducting Novartis Biotechnology Leadership Camp (BioCamp) at Hyderabad from July 30 to August 1, 2012 and invited students to participate from 100 Indian universities.

immatics Wins 2012 TiE50 AwardTUEBINGEN, Germany, May 25, 2012 /PRNewswire/ -- immatics chosen as a leading company in the life sciences category by the world's largest entrepreneurial network immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that it has been named a 2012 TiE50 winner. These prestigious awards re...

ICH Q11 Accord Brings QbD to APIs, Defines API Starting MaterialsAfter five years, working group members of the International Conference on Harmonization have adopted its Q11 guideline on drug substance development and manufacture, which advances QbD principles for drug substance development, especially for biotec...

Groups Ask Senate to Reconsider NDAA Amendments Blocking Military Use of Alternative EnergyThe Advanced Biofuels Association, the Algal Biomass Organization, Airlines for America, the American Farm Bureau Federation, the Biotechnology Industry Organization, Growth Energy, and the Pew Charitable Trusts today expressed disappointment that the Senate Armed Services Committee adopted amendments to the National Defense Authorization Act blocking the...

Zurich Heart Center Presents Clinical Experience with eSVS® Mesh at International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual MeetingManny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS) announced that Prof. Michele Genoni, MD, Chief of Cardiovascular Surgery of the Triemli Hospital, Zurich, Switzerland will be presenting his center’s early clinical experience with the eSVS® Mesh device at the 14th Annual meeting of the ISMICS in Los Angeles, CA. He will be presen...

BIO Lauds Senate Passage of User Fee PackageBiotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in support of the U.S. Senate’s approval of the Food and Drug Administration Safety and Innovation Act (FDASIA): “BIO commends the bipartisan Senate approval of FDASIA, which includes a reauthorization of the Prescription Drug User Fee Act...

Microorganism ID: Bacteria Identification Service by Altogen LabsAltogen Labs CRO, a preclinical contract research laboratory, announced its launch of microorganism ID bacteria identification service today. Microorganism identification and bioinformatic sequence characterization services are avail

J.G. Finneran Introduces Snap Seal™ Vials and Snap Top Caps™ for the 96 Well Multi Tier™ Micro Plate SystemPatented sample vials and closures form a sealing system for use with autosamplers and robotic equipment. Vineland, NJ (PRWEB) May 24, 2012 Chemists can secure samples in a snap with a new system for automated high-throughput sampling. J.G. Finneran Associates, a manufacturer and supplier of unique and innovative products for the global chromatography, biotechnology, and environmental research co...

Integration of resources fuels clinical drug development in Denmark - new legislation speeds up the trial approval process, making Denmark one of the fastest locations in Europe.Lars Arendt-Nielsen delivers keynote speech on: “Excellence in Early Drug Development” at the 9th annual Anglonordic Biotech Conference, held on 24 May 2012 in London. Denmark is one of the best places to perform high-quality clinical trials. New legislation speeds up the trial approval process, making it one of the fastest in Europe. Eir, a new Danish health and life science b...

French biotech sector strugglingFallout from the economic crisis continues to cast a pall over the French life-science sector. The number of new firms created in 2011 plunged 47%, from 46 in 2010 to 24 last year, and the number of closures soared by 400%, from 5 in 2008 to 25 in 20...

0 1 2 3 4 ›»

buy Biotechnology market research data and corporate reports now Advertisement